MayTech Global Investments’s Pacira BioSciences PCRX Stock Holding History

MayTech Global Investments’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$11.6K	–	48
2022 Q4	$11.6K	Buy	+300	New	+$14.6K	﹤0.01%	59
2022 Q3	–	Sell	-300	Closed	-$17K	–	56
2022 Q2	$17K	Hold	300	–	–	0.01%	65
2022 Q1	$23K	Hold	300	–	–	0.01%	69
2021 Q4	$18K	Hold	300	–	–	﹤0.01%	73
2021 Q3	$17K	Hold	300	–	–	﹤0.01%	61
2021 Q2	$18K	Hold	300	–	–	﹤0.01%	59
2021 Q1	$21K	Hold	300	–	–	0.01%	51
2020 Q4	$18K	Hold	300	–	–	﹤0.01%	49
2020 Q3	$18K	Hold	300	–	–	﹤0.01%	46
2020 Q2	$16K	Hold	300	–	–	0.01%	47
2020 Q1	$10K	Hold	300	–	–	﹤0.01%	46
2019 Q4	$14K	Hold	300	–	–	0.01%	46
2019 Q3	$11K	Hold	300	–	–	0.01%	41
2019 Q2	$13K	Hold	300	–	–	0.01%	42
2019 Q1	$11K	Hold	300	–	–	0.01%	41
2018 Q4	$13K	Buy	+300	New	+$14K	0.01%	39

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

MayTech Global Investments's PCRX Position: Q1 2023 in Review

MayTech Global Investments sold out of Pacira BioSciences (PCRX) in Q1 2023, closing a stake of 300 shares — an estimated $11.6K sold.

MayTech Global Investments first reported a position in PCRX in Q4 2018 and held it in 16 quarters. The position peaked at $23K in Q1 2022. 267 funds tracked by Wall St. Rank hold PCRX as of Q1 2023.

MayTech Global Investments reported no remaining Pacira BioSciences position as of Q1 2023 after selling out during the quarter.
MayTech Global Investments sold 300 Pacira BioSciences shares in Q1 2023, an estimated $11.6K.
MayTech Global Investments first reported a position in Pacira BioSciences in Q4 2018 and held it in 16 quarters.
MayTech Global Investments's Pacira BioSciences position peaked at $23K in Q1 2022.
267 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2023.

Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.